Lemaitre Vascular (LMAT) Capital Expenditures (2010 - 2026)

Lemaitre Vascular (LMAT) has 17 years of Capital Expenditures data on file, last reported at $2.8 million in Q1 2026.

• Quarterly Capital Expenditures rose 101.23% year-over-year to $2.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.2 million (up 17.32% YoY) and the FY2025 annual result came in at $6.8 million, down 2.57% from the prior year.
• Capital Expenditures rose to $2.8 million in Q1 2026 per LMAT's latest filing, from $1.8 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $2.8 million in Q2 2023 and bottomed at $460000.0 in Q3 2022.
• The 5-year median for Capital Expenditures is $1.4 million (2025), against an average of $1.6 million.
• The widest annual swing landed in 2022, when Capital Expenditures slumped 74.64%; it then jumped 297.39% in 2023.
• Tracing LMAT's Capital Expenditures over 5 years: stood at $1.3 million in 2022, then climbed by 1.51% to $1.3 million in 2023, then surged by 59.81% to $2.0 million in 2024, then retreated by 13.06% to $1.8 million in 2025, then jumped by 56.61% to $2.8 million in 2026.
• Per Business Quant, the three latest LMAT Capital Expenditures figures stand at $2.8 million (Q1 2026), $1.8 million (Q4 2025), and $2.3 million (Q3 2025).

Peer Comparison